NCT02235662View on ClinicalTrials.gov

Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
HIVContraception
Interventions
DRUG

TFV IVR

DRUG

TFV/LNG IVR

OTHER

Placebo IVR

Trial Locations (2)

23507

Eastern Virginia Medical School, Norfolk

Unknown

Profamilia, Santo Domingo

All Listed Sponsors
lead

CONRAD

OTHER

NCT02235662 - Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone | Biotech Hunter | Biotech Hunter